Publication | Open Access

Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes

ObesityMetabolic SyndromeDiabetes ManagementBody CompositionHealth SciencesMedicinePhysiologyDiabetesType 2Diabetes MellitusMetabolismPharmacologySkeletal Muscle AmountSodium-glucose Co-transporter 2